By preparing tumor cell suspensions via collagenase digestion of excised tumors, we found that the combination of SFN and anti-CTLA-4 resulted in a more pronounced upregulation of CD8+ CTL population within tumor-infiltrating lymphocytes (TILs) compared to monotherapy (Fig. 7G, Fig. S6H). Here, CTLA4 is linked to neoplasm.